Vivo Biosciences Inc
1601 12th Avenue South
Vivo Biosciences Inc. (VBI), an early stage biotech company founded in 2004, has developed new ‘all-human’ bioassay platforms for preclinical research, drug discovery and therapeutics. The company relies on its patented HuBiogel™ technology which emulates the biology of normal and disease tissues in vitro. A series of 3-D or Mini-tumor bioassay systems are developed for rapid analysis of drug efficacy, toxicity and therapy prediction, the major bottlenecks of current drug development pipeline. This high-value technology is offered worldwide to academic, commercial and government institutions.
President, CEO and CSO: Raj Singh, PhD